RECRUITING

Measuring Acute Drug Demand in Humans

Talk to us

Conditions

Opioid Use DisorderOpioid Dependence

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research is being done to evaluate whether suvorexant may reduce the use of, subjective liking, and demand for various drugs.

Official Title

Measuring Acute Drug Demand in Humans

Quick Facts

Study Start:2023-08-08
Study Completion:2027-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05829655

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age between 18 and 65 years old
  2. * Meets Diagnostic and Statistical Manual-5 criteria for Opioid Use Disorder (OUD) (moderate or severe)
  3. * Lifetime substance use history criterion \[blinded\]
  4. * Medically cleared to take suvorexant and blinded study medications
  5. * Be in good general health based on a physical examination, medical history, vital signs, and screening urine and blood tests
  1. * Pregnant or breast feeding
  2. * Seeking opioid use treatment
  3. * Significant mental health or physical disorder that is expected to interfere with study participation as assessed by the study physicians or medical staff
  4. * Known contraindications or allergies to suvorexant and/or the blinded study medications

Contacts and Locations

Study Contact

Justin Strickland, PhD
CONTACT
(410) 550-1975
jstric14@jhmi.edu

Principal Investigator

Justin Strickland, PhD
PRINCIPAL_INVESTIGATOR
Johns Hopkins University

Study Locations (Sites)

Behavioral Pharmacology Research Unit
Baltimore, Maryland, 21224
United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

  • Justin Strickland, PhD, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-08
Study Completion Date2027-10-31

Study Record Updates

Study Start Date2023-08-08
Study Completion Date2027-10-31

Terms related to this study

Additional Relevant MeSH Terms

  • Opioid Use Disorder
  • Opioid Dependence